BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 32201081)

  • 1. Poziotinib suppresses ovarian cancer stem cell growth via inhibition of HER4-mediated STAT5 pathway.
    Lee H; Kim JW; Choi DK; Yu JH; Kim JH; Lee DS; Min SH
    Biochem Biophys Res Commun; 2020 May; 526(1):158-164. PubMed ID: 32201081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined Poziotinib with Manidipine Treatment Suppresses Ovarian Cancer Stem-Cell Proliferation and Stemness.
    Lee H; Kim JW; Lee DS; Min SH
    Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33036254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Midkine downregulation increases the efficacy of quercetin on prostate cancer stem cell survival and migration through PI3K/AKT and MAPK/ERK pathway.
    Erdogan S; Turkekul K; Dibirdik I; Doganlar O; Doganlar ZB; Bilir A; Oktem G
    Biomed Pharmacother; 2018 Nov; 107():793-805. PubMed ID: 30142541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gamma-Secretase Inhibitor IX (GSI) Impairs Concomitant Activation of Notch and Wnt-Beta-Catenin Pathways in CD44
    Barat S; Chen X; Cuong Bui K; Bozko P; Götze J; Christgen M; Krech T; Malek NP; Plentz RR
    Stem Cells Transl Med; 2017 Mar; 6(3):819-829. PubMed ID: 28186678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Zoledronic acid inhibits the growth of cancer stem cell derived from cervical cancer cell by attenuating their stemness phenotype and inducing apoptosis and cell cycle arrest through the Erk1/2 and Akt pathways.
    Wang L; Liu Y; Zhou Y; Wang J; Tu L; Sun Z; Wang X; Luo F
    J Exp Clin Cancer Res; 2019 Feb; 38(1):93. PubMed ID: 30791957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repositioning Trimebutine Maleate as a Cancer Treatment Targeting Ovarian Cancer Stem Cells.
    Lee H; Kwon OB; Lee JE; Jeon YH; Lee DS; Min SH; Kim JW
    Cells; 2021 Apr; 10(4):. PubMed ID: 33923707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcium Channels as Novel Therapeutic Targets for Ovarian Cancer Stem Cells.
    Lee H; Kim JW; Kim DK; Choi DK; Lee S; Yu JH; Kwon OB; Lee J; Lee DS; Kim JH; Min SH
    Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32230901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autotaxin Regulates Maintenance of Ovarian Cancer Stem Cells through Lysophosphatidic Acid-Mediated Autocrine Mechanism.
    Seo EJ; Kwon YW; Jang IH; Kim DK; Lee SI; Choi EJ; Kim KH; Suh DS; Lee JH; Choi KU; Lee JW; Mok HJ; Kim KP; Matsumoto H; Aoki J; Kim JH
    Stem Cells; 2016 Mar; 34(3):551-64. PubMed ID: 26800320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dietary compound proanthocyanidins from Chinese bayberry (Myrica rubra Sieb. et Zucc.) leaves attenuate chemotherapy-resistant ovarian cancer stem cell traits via targeting the Wnt/β-catenin signaling pathway and inducing G1 cell cycle arrest.
    Zhang Y; Chen S; Wei C; Rankin GO; Ye X; Chen YC
    Food Funct; 2018 Jan; 9(1):525-533. PubMed ID: 29256569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ursolic acid inhibits proliferation and reverses drug resistance of ovarian cancer stem cells by downregulating ABCG2 through suppressing the expression of hypoxia-inducible factor-1α in vitro.
    Wang WJ; Sui H; Qi C; Li Q; Zhang J; Wu SF; Mei MZ; Lu YY; Wan YT; Chang H; Guo PT
    Oncol Rep; 2016 Jul; 36(1):428-40. PubMed ID: 27221674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. WM130 preferentially inhibits hepatic cancer stem-like cells by suppressing AKT/GSK3β/β-catenin signaling pathway.
    Ni CX; Qi Y; Zhang J; Liu Y; Xu WH; Xu J; Hu HG; Wu QY; Wang Y; Zhang JP
    Oncotarget; 2016 Nov; 7(48):79544-79556. PubMed ID: 27783993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NOR1 Suppresses Cancer Stem-Like Cells Properties of Tumor Cells via the Inhibition of the AKT-GSK-3β-Wnt/β-catenin-ALDH1A1 Signal Circuit.
    Wang W; Yi M; Chen S; Li J; Zhang H; Xiong W; Li G; Li X; Xiang B
    J Cell Physiol; 2017 Oct; 232(10):2829-2840. PubMed ID: 27891591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aryl hydrocarbon receptor/cytochrome P450 1A1 pathway mediates breast cancer stem cells expansion through PTEN inhibition and β-Catenin and Akt activation.
    Al-Dhfyan A; Alhoshani A; Korashy HM
    Mol Cancer; 2017 Jan; 16(1):14. PubMed ID: 28103884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Wogonin induces apoptosis and down-regulates survivin in human breast cancer MCF-7 cells by modulating PI3K-AKT pathway.
    Huang KF; Zhang GD; Huang YQ; Diao Y
    Int Immunopharmacol; 2012 Feb; 12(2):334-41. PubMed ID: 22182776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytoprotective effect of neuropeptides on cancer stem cells: vasoactive intestinal peptide-induced antiapoptotic signaling.
    Sastry KS; Chouchane AI; Wang E; Kulik G; Marincola FM; Chouchane L
    Cell Death Dis; 2017 Jun; 8(6):e2844. PubMed ID: 28569785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ginsenoside-Rb1 targets chemotherapy-resistant ovarian cancer stem cells via simultaneous inhibition of Wnt/β-catenin signaling and epithelial-to-mesenchymal transition.
    Deng S; Wong CKC; Lai HC; Wong AST
    Oncotarget; 2017 Apr; 8(16):25897-25914. PubMed ID: 27825116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. KLF5 strengthens drug resistance of ovarian cancer stem-like cells by regulating survivin expression.
    Dong Z; Yang L; Lai D
    Cell Prolif; 2013 Aug; 46(4):425-35. PubMed ID: 23869764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sonic hedgehog and Wnt/β-catenin pathways mediate curcumin inhibition of breast cancer stem cells.
    Li X; Wang X; Xie C; Zhu J; Meng Y; Chen Y; Li Y; Jiang Y; Yang X; Wang S; Chen J; Zhang Q; Geng S; Wu J; Zhong C; Zhao Y
    Anticancer Drugs; 2018 Mar; 29(3):208-215. PubMed ID: 29356693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. XIAP Limits Autophagic Degradation of Sox2 and Is A Therapeutic Target in Nasopharyngeal Carcinoma Stem Cells.
    Ji J; Yu Y; Li ZL; Chen MY; Deng R; Huang X; Wang GF; Zhang MX; Yang Q; Ravichandran S; Feng GK; Xu XL; Yang CL; Qiu MZ; Jiao L; Yang D; Zhu XF
    Theranostics; 2018; 8(6):1494-1510. PubMed ID: 29556337
    [No Abstract]   [Full Text] [Related]  

  • 20. α-Mangostin-encapsulated PLGA nanoparticles inhibit colorectal cancer growth by inhibiting Notch pathway.
    Chandra Boinpelly V; Verma RK; Srivastav S; Srivastava RK; Shankar S
    J Cell Mol Med; 2020 Oct; 24(19):11343-11354. PubMed ID: 32830433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.